Aflibercept-related sterile inflammation

Ophthalmology. 2013 May;120(5):1100-101.e1-5. doi: 10.1016/j.ophtha.2012.11.018.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Angiogenesis Inhibitors / adverse effects*
  • Female
  • Humans
  • Injections, Intraocular
  • Macular Degeneration / drug therapy
  • Male
  • Middle Aged
  • Receptors, Vascular Endothelial Growth Factor / adverse effects*
  • Recombinant Fusion Proteins / adverse effects*
  • Uveitis / chemically induced*

Substances

  • Angiogenesis Inhibitors
  • Recombinant Fusion Proteins
  • aflibercept
  • Receptors, Vascular Endothelial Growth Factor